{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T17:38:10Z","timestamp":1769362690567,"version":"3.49.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2008,10,18]],"date-time":"2008-10-18T00:00:00Z","timestamp":1224288000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1007\/s00277-008-0626-1","type":"journal-article","created":{"date-parts":[[2008,10,17]],"date-time":"2008-10-17T09:14:13Z","timestamp":1224234853000},"page":"485-490","source":"Crossref","is-referenced-by-count":37,"title":["6 versus 30\u00a0months anticoagulation for recurrent venous thrombosis in patients with high factor VIII"],"prefix":"10.1007","volume":"88","author":[{"name":"for the AUREC-FVIII investigators (as listed in acknowledgements)","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Eischer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Gartner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Schulman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. A.","family":"Kyrle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Eichinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,10,18]]},"reference":[{"key":"626_CR1","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0140-6736(95)90166-3","volume":"345","author":"T Koster","year":"1995","unstructured":"Koster T, Blann AD, Briet E, Vandenbroucke JP, Rosendaal FR (1995) Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet 345:152\u2013155 doi: 10.1016\/S0140-6736(95)90166-3","journal-title":"Lancet"},{"key":"626_CR2","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1055\/s-0038-1656061","volume":"77","author":"J O\u2019Donnell","year":"1997","unstructured":"O\u2019Donnell J, Tuddenham EG, Manning R, Kemball-Cook G, Johnson D, Laffan M (1997) High prevalence of high factor VIII levels in patients referred for thrombophilia screening: role of increased synthesis and relationship to the acute phase reaction. Thromb Haemost 77:825\u2013828","journal-title":"Thromb Haemost"},{"key":"626_CR3","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1056\/NEJM200008173430702","volume":"343","author":"PA Kyrle","year":"2000","unstructured":"Kyrle PA, Minar E, Hirschl M, Bialonczyk C, Stain M, Schneider B, Weltermann A, Speiser W, Lechner K, Eichinger S (2000) High plasma levels of factor levels and the risk of recurrent venous thromboembolism. N Engl J Med 343:457\u2013462 doi: 10.1056\/NEJM200008173430702","journal-title":"N Engl J Med"},{"key":"626_CR4","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1046\/j.1365-2141.2003.04795.x","volume":"124","author":"L Cristina","year":"2004","unstructured":"Cristina L, Benilde C, Michela C, Mirella F, Giuliana G, Gualtiero P (2004) High plasma levels of factor VIII and risk of recurrence of venous thromboembolism. Br J Haematol 124:504\u2013510 doi: 10.1046\/j.1365-2141.2003.04795.x","journal-title":"Br J Haematol"},{"key":"626_CR5","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1001\/jama.293.19.2352","volume":"293","author":"SC Christiansen","year":"2005","unstructured":"Christiansen SC, Cannegieter SC, Koster T, Vandenbroucke JP, Rosendaal FR (2005) Thrombophilia, clinical factors, and recurrent venous thrombotic events. JAMA 293:2352\u20132361 doi: 10.1001\/jama.293.19.2352","journal-title":"JAMA"},{"key":"626_CR6","doi-asserted-by":"crossref","first-page":"287S","DOI":"10.1378\/chest.126.3_suppl.287S","volume":"126","author":"MN Levine","year":"2004","unstructured":"Levine MN, Raskob G, Beyth RJ, Kearon C, Schulman S (2004) Hemorrhagic complications of anticoagulant treatment: the Seventh ACCP Conference on Antithrombotic and hrombolytic Therapy. Chest 126:287S\u2013310S","journal-title":"Chest"},{"key":"626_CR7","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1056\/NEJM199506223322501","volume":"332","author":"S Schulman","year":"1995","unstructured":"Schulman S, Rhedin AS, Lindmarker P, Carlsson A, Larfars G, Nicol P, Loogna E, Svensson E, Ljungberg B, Walter H, Viering S, Nordlander S, Leijd B, Kjell-Ake J, Hjorth M, Linder O, Boberg J, Duration of Anticoagulation Trial Study Group (1995) A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. N Engl J Med 332:1661\u20131665 doi: 10.1056\/NEJM199506223322501","journal-title":"N Engl J Med"},{"key":"626_CR8","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJM199702063360601","volume":"336","author":"S Schulman","year":"1997","unstructured":"Schulman S, Granqvist S, Holmstrom M, Carlsson A, Lindmarker P, Nicol P, Eklund SG, Nordlander S, Larfars G, Leijd B, Linder O, Loogna E (1997) The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. The Duration of Anticoagulation Trial Study Group. N Engl J Med 336:393\u2013398 doi: 10.1056\/NEJM199702063360601","journal-title":"N Engl J Med"},{"key":"626_CR9","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0140-6736(96)01109-9","volume":"348","author":"G Palareti","year":"1996","unstructured":"Palareti G, Leali N, Coccheri S, Poggi M, Manotti C, D\u2019Angelo A, Pengo V, Erba N, Moia M, Ciavarella N, Devoto G, Berrettini M, Musolesi S (1996) Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy. Lancet 348:423\u2013428 doi: 10.1016\/S0140-6736(96)01109-9","journal-title":"Lancet"},{"key":"626_CR10","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1055\/s-0038-1650514","volume":"76","author":"FJ Meer van der","year":"1996","unstructured":"van der Meer FJ, Rosendaal FR, Vandenbroucke JP, Briet E (1996) Assessment of a bleeding risk index in two cohorts of patients treated with oral anticoagulants. Thromb Haemost 76:12\u201316","journal-title":"Thromb Haemost"},{"key":"626_CR11","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"EL Kaplan","year":"1958","unstructured":"Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457\u2013481 doi: 10.2307\/2281868","journal-title":"J Am Stat Assoc"},{"key":"626_CR12","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0140-6736(00)04337-3","volume":"357","author":"D Moher","year":"2001","unstructured":"Moher D, Schulz KF, Altman DG (2001) The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 357:1191\u20131194 doi: 10.1016\/S0140-6736(00)04337-3","journal-title":"Lancet"},{"key":"626_CR13","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1056\/NEJM200107193450302","volume":"345","author":"G Agnelli","year":"2001","unstructured":"Agnelli G, Prandoni P, Santamaria MG, Bagatella P, Iorio A, Bazzan M, Moia M, Guazzaloca G, Bertoldi A, Tomasi C, Scannapieco G, Ageno W, Warfarin Optimal Duration Italian Trial Investigators (2001) Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. Warfarin Optimal Duration Italian Trial Investigators. N Engl J Med 345:165\u2013169 doi: 10.1056\/NEJM200107193450302","journal-title":"N Engl J Med"},{"key":"626_CR14","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1056\/NEJMoa032959","volume":"350","author":"PA Kyrle","year":"2004","unstructured":"Kyrle PA, Minar E, Bialonczyk C, Hirschl M, Weltermann A, Eichinger S (2004) The risk of recurrent venous thromboembolism in men and women. N Engl J Med 350:2558\u20132563 doi: 10.1056\/NEJMoa032959","journal-title":"N Engl J Med"},{"key":"626_CR15","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1001\/archinte.164.1.92","volume":"164","author":"S Eichinger","year":"2004","unstructured":"Eichinger S, Weltermann A, Minar E, Stain M, Sch\u00f6nauer V, Schneider B, Kyrle PA (2004) Symptomatic pulmonary embolism and the risk of recurrent venous thromboembolism. Arch Intern Med 164:92\u201396 doi: 10.1001\/archinte.164.1.92","journal-title":"Arch Intern Med"},{"key":"626_CR16","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1055\/s-0037-1613230","volume":"88","author":"S Murin","year":"2002","unstructured":"Murin S, Romano PS, White RH (2002) Comparison of outcomes after hospitalization for deep venous thrombosis or pulmonary embolism. Thromb Haemost 88:407\u2013414","journal-title":"Thromb Haemost"},{"key":"626_CR17","doi-asserted-by":"crossref","first-page":"766","DOI":"10.7326\/0003-4819-147-11-200712040-00007","volume":"147","author":"JD Douketis","year":"2007","unstructured":"Douketis JD, Gu CS, Schulman S, Ghirarduzzi A, Pengo V, Prandoni P (2007) The risk for fatal pulmonary embolism after discontinuing anticoagulant therapy for venous thromboembolism. Ann Intern Med 147:766\u2013774","journal-title":"Ann Intern Med"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-008-0626-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-008-0626-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-008-0626-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T07:59:05Z","timestamp":1589011145000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-008-0626-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10,18]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["626"],"URL":"https:\/\/doi.org\/10.1007\/s00277-008-0626-1","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,10,18]]}}}